A detailed history of Optas, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Optas, LLC holds 3,500 shares of ABT stock, worth $357,420. This represents 0.11% of its overall portfolio holdings.

Number of Shares
3,500
Previous 3,395 3.09%
Holding current value
$357,420
Previous $373,000 6.43%
% of portfolio
0.11%
Previous 0.11%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 17, 2024

BUY
$109.52 - $120.96 $11,499 - $12,700
105 Added 3.09%
3,500 $397,000
Q4 2023

Jan 25, 2024

BUY
$90.19 - $110.4 $13,438 - $16,449
149 Added 4.59%
3,395 $373,000
Q3 2023

Oct 31, 2023

SELL
$95.53 - $114.62 $6,973 - $8,367
-73 Reduced 2.2%
3,246 $314,000
Q2 2023

Jul 20, 2023

BUY
$100.78 - $112.29 $4,837 - $5,389
48 Added 1.47%
3,319 $361,000
Q1 2023

Apr 17, 2023

BUY
$96.86 - $114.01 $13,657 - $16,075
141 Added 4.5%
3,271 $331,000
Q4 2022

Jan 27, 2023

BUY
$95.06 - $111.52 $6,083 - $7,137
64 Added 2.09%
3,130 $343,000
Q3 2022

Oct 31, 2022

BUY
$96.76 - $112.03 $11,320 - $13,107
117 Added 3.97%
3,066 $297,000
Q2 2022

Aug 01, 2022

BUY
$102.07 - $123.37 $36,949 - $44,659
362 Added 13.99%
2,949 $320,000
Q1 2022

Apr 26, 2022

BUY
$114.02 - $139.04 $10,147 - $12,374
89 Added 3.56%
2,587 $306,000
Q4 2021

Jan 26, 2022

BUY
$115.53 - $141.46 $462 - $565
4 Added 0.16%
2,498 $351,000
Q3 2021

Oct 14, 2021

BUY
$116.66 - $129.06 $16,215 - $17,939
139 Added 5.9%
2,494 $295,000
Q2 2021

Jul 27, 2021

SELL
$105.79 - $124.53 $6,664 - $7,845
-63 Reduced 2.61%
2,355 $273,000
Q1 2021

Apr 19, 2021

BUY
$108.84 - $128.23 $11,210 - $13,207
103 Added 4.45%
2,418 $289,000
Q4 2020

Jan 27, 2021

SELL
$105.0 - $114.42 $211,575 - $230,556
-2,015 Reduced 46.54%
2,315 $253,000
Q3 2020

Oct 23, 2020

BUY
$91.64 - $111.29 $396,801 - $481,885
4,330 New
4,330 $472,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $179B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Optas, LLC Portfolio

Follow Optas, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Optas, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Optas, LLC with notifications on news.